Page last updated: 2024-09-04

docetaxel anhydrous and asparagine

docetaxel anhydrous has been researched along with asparagine in 2 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(asparagine)
Trials
(asparagine)
Recent Studies (post-2010) (asparagine)
12,1103,2166,9206,819411,398

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreu, JM; Barasoain, I; Buey, RM; Calvo, E; Cerezo, G; Day, BW; Díaz, JF; Edler, MC; Hamel, E; López, JA; Matesanz, R; Pineda, O; Sorensen, EJ; Vanderwal, CD1
Alonso, MJ; Benoit, JP; Lollo, G; Montier, T; Passirani, C; Rivera-Rodriguez, GR; Torres, D1

Other Studies

2 other study(ies) available for docetaxel anhydrous and asparagine

ArticleYear
Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
    Nature chemical biology, 2007, Volume: 3, Issue:2

    Topics: Alkanes; Amino Acid Sequence; Asparagine; Binding Sites; Binding, Competitive; Carbamates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Docetaxel; Epothilones; Humans; Inhibitory Concentration 50; Lactones; Mass Spectrometry; Microtubules; Models, Chemical; Models, Molecular; Molecular Sequence Data; Paclitaxel; Polycyclic Compounds; Protein Binding; Pyrones; Taxoids; Threonine; Tubulin; Tubulin Modulators

2007
In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    International journal of pharmaceutics, 2013, Dec-15, Volume: 458, Issue:1

    Topics: Animals; Antineoplastic Agents; Asparagine; Cell Line, Tumor; Chemistry, Pharmaceutical; Docetaxel; Drug Carriers; Drug Delivery Systems; Glioma; Mice; Nanocapsules; Particle Size; Taxoids; Tissue Distribution

2013